INVALID TRIAL
CHIA and your personal trial have no criteria in common

Only your personal trial has the following criteria:
╒════════════════════════════════════════════════════╤═════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria   │   Score │
╞════════════════════════════════════════════════════╪═════════════════╪═════════╡
│ Male or female patients ≥ 18 years of age referred │ NA              │       0 │
│ to Indiana University Health, University Hospital  │                 │         │
│ for ERCP for a biliary indication, at the          │                 │         │
│ discretion of the treating MD (e.g. suspected      │                 │         │
│ common bile duct stone, initial post-liver         │                 │         │
│ transplant evaluation, suspected or confirmed      │                 │         │
│ cholangiocarcinoma, suspected primary sclerosing   │                 │         │
│ cholangitis -- see exclusion criterion #12)        │                 │         │
├────────────────────────────────────────────────────┼─────────────────┼─────────┤
│ Must have minimum age of 18 Years                  │ NA              │       0 │
├────────────────────────────────────────────────────┼─────────────────┼─────────┤
│ Pregnant woman or breast feeding                   │ NA              │       0 │
├────────────────────────────────────────────────────┼─────────────────┼─────────┤
│ Patient unable to give informed consent            │ NA              │       0 │
├────────────────────────────────────────────────────┼─────────────────┼─────────┤
│ Patient with a history of pancreatic surgery       │ NA              │       0 │
├────────────────────────────────────────────────────┼─────────────────┼─────────┤
│ Patient with a history of pancreatic cancer        │ NA              │       0 │
├────────────────────────────────────────────────────┼─────────────────┼─────────┤
│ Patient with a history of acute or chronic         │ NA              │       0 │
│ pancreatitis                                       │                 │         │
├────────────────────────────────────────────────────┼─────────────────┼─────────┤
│ Patient with radiographic evidence of acute or     │ NA              │       0 │
│ chronic pancreatitis on CT, MRCP, or EUS           │                 │         │
├────────────────────────────────────────────────────┼─────────────────┼─────────┤
│ Patient with a current or prior history of average │ NA              │       0 │
│ daily alcohol consumption of greater than 60 g per │                 │         │
│ day for more than 2 years                          │                 │         │
├────────────────────────────────────────────────────┼─────────────────┼─────────┤
│ Patient with a history of cigarette smoking        │ NA              │       0 │
│ greater that 20 pack-years                         │                 │         │
├────────────────────────────────────────────────────┼─────────────────┼─────────┤
│ Patient with a history of pancreas divisum         │ NA              │       0 │
├────────────────────────────────────────────────────┼─────────────────┼─────────┤
│ Evidence of chronic pancreatitis on pancreatogram  │ NA              │       0 │
│ during ERCP                                        │                 │         │
├────────────────────────────────────────────────────┼─────────────────┼─────────┤
│ ERCP for an isolated biliary indication with       │ NA              │       0 │
│ previous biliary sphincterotomy or for biliary     │                 │         │
│ stent exchange, when pancreatic entry should       │                 │         │
│ easily be avoided by the endoscopist               │                 │         │
├────────────────────────────────────────────────────┼─────────────────┼─────────┤
│ History of allergy or adverse reactions to         │ NA              │       0 │
│ secretin                                           │                 │         │
├────────────────────────────────────────────────────┼─────────────────┼─────────┤
│ Age \<18 years                                     │ NA              │      12 │
╘════════════════════════════════════════════════════╧═════════════════╧═════════╛

Only CHIA has the following criteria:
╒═════════════════════╤═════════════════╤═════════╕
│ Personal Criteria   │ CHIA Criteria   │   Score │
╞═════════════════════╪═════════════════╪═════════╡
│ Age \<18 years      │ NA              │      12 │
├─────────────────────┼─────────────────┼─────────┤
│ Age \<18 years      │ NA              │      12 │
╘═════════════════════╧═════════════════╧═════════╛

Levenshtein Ratio of Entire trial at once: 0
Average Levenshtein Ratio of individual lines: 2.1176470588235294
OverAll Ratio: 1.0588235294117647
